function mrInclude3() { 
	document.write("<div class='StoryText'><div class='NewsIndexDate'>08-Oct-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200810/1257684_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Early data show potential for imatinib to treat life-threatening form of pulmonary artery disease</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>07-Oct-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200810/1257283_5_2.html\",680,850,\"Y\",\"Y\");return false;'>New Phase II data on NVA237, a novel once-daily treatment for COPD, show promising efficacy and tolerability with potentially faster onset than tiotropium</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>06-Oct-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200810/1257049_5_2.html\",680,850,\"Y\",\"Y\");return false;'>New study shows potential benefits of innovative Xolair® anti-IgE therapy in treating children suffering from moderate-to-severe allergic asthma </a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div>");
}

function mrInclude20() { 
	document.write("<div class='StoryText'><div class='NewsIndexDate'>08-Oct-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200810/1257684_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Early data show potential for imatinib to treat life-threatening form of pulmonary artery disease</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>07-Oct-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200810/1257283_5_2.html\",680,850,\"Y\",\"Y\");return false;'>New Phase II data on NVA237, a novel once-daily treatment for COPD, show promising efficacy and tolerability with potentially faster onset than tiotropium</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>06-Oct-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200810/1257049_5_2.html\",680,850,\"Y\",\"Y\");return false;'>New study shows potential benefits of innovative Xolair® anti-IgE therapy in treating children suffering from moderate-to-severe allergic asthma </a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>30-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1255392_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Once-yearly Aclasta® approved in EU to treat osteoporosis in men and to reduce risk of new fractures following hip fracture both in men and postmenopausal women</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>25-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1254262_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Novartis starts ''squeeze out'' procedure for remaining Speedel shares</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>19-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1252754_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Novartis MF59®-adjuvanted vaccine rapidly induces protective antibody levels against diverse strains of avian flu </a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>16-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1251556_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Latest RAD001 study results show further increase in time without tumor growth in patients with advanced kidney cancer</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>15-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1251164_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Novartis receives FDA priority review for Coartem®, potentially the first artemisinin-based combination treatment (ACT) for malaria in the US</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>13-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1251089_5_2.html\",680,850,\"Y\",\"Y\");return false;'>RAD001 combined with Sandostatin® LAR® and as monotherapy controls growth of rare pancreatic neuroendocrine tumors</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>10-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1250239_5_2.html\",680,850,\"Y\",\"Y\");return false;'>New Phase II data show Novartis investigational Meningitis B vaccine may also protect infants six months and older</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>09-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1249901_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Data show Galvus® better tolerated by patients with type 2 diabetes, with no weight gain, a favorable cardiovascular profile and equal efficacy compared to widely-used TZDs </a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>09-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1249860_5_2.html\",680,850,\"Y\",\"Y\");return false;'>RAD001 granted priority review in the US based on potential to fill unmet medical need in patients with advanced kidney cancer</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>03-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1248468_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Rasilez® , first-in-class direct renin inhibitor, lowers high blood pressure more effectively than diuretic in obese patients</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>03-Sep-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200809/1248342_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Sandoz receives FDA approval for Omnitrope® Pen 10 with liquid cartridge</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>29-Aug-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200808/1247203_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Novartis decides not to pursue further development of Aurograb(TM) </a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>27-Aug-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200808/1246407_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Glivec receives FDA priority review as first therapy to reduce recurrence of gastrointestinal stromal tumors after surgery</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>27-Aug-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200808/1246393_5_2.html\",680,850,\"Y\",\"Y\");return false;'>NICE final guidance recommends Lucentis® as cost-effective treatment for wet AMD, a leading cause of blindness</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>07-Aug-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200808/1241557_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Novartis begins shipment to US of Fluvirin® Influenza Virus Vaccine with three new strains for the 2008-2009 influenza season</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>04-Aug-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200808/1239786_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Single-pill combinations Diovan HCT® and Exforge® approved in US as first-line treatments for high blood pressure</a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div><div class='StoryText'><div class='NewsIndexDate'>28-Jul-2008</div><div class='NewsIndexTitle'><a href='javascript:;' onClick='openwin(\"http://cws.huginonline.com/N/134323/PR/200807/1238536_5_2.html\",680,850,\"Y\",\"Y\");return false;'>Exforge® helps nearly twice as many patients control their high blood pressure compared to amlodipine alone </a></div><div class='NewsIndexDivider'><img src='/pkg_cfg/b.gif' width='1' height='1' alt=''></div>");
}